Literature DB >> 10755036

Health care implications of dysfunctional uterine bleeding.

A Prentice1.   

Abstract

Objective menorrhagia (measured menstrual blood loss of > 80 ml) affects approximately 10% of the population, while the subjective complaint of menorrhagia is experienced by almost a third of the female population of childbearing age. Consequently, large numbers of women consult their general practitioners annually and many are subsequently referred on for gynaecological opinion. Ineffective utilization of medical therapies may result in inappropriate referral and subsequently may result in operative intervention. The introduction of many minimally invasive techniques to manage menorrhagia has not brought about the expected reduction in surgical intervention rates but has merely increased the overall operative burden on the National Health Service (NHS). Recent advances in medical therapy may, for the first time, offer a rational and effective alternative to surgical therapy but long-term clinical and cost effectiveness studies are required. At present menorrhagia continues to be a major drain on health care resources.

Entities:  

Mesh:

Year:  1999        PMID: 10755036     DOI: 10.1053/beog.1999.0016

Source DB:  PubMed          Journal:  Baillieres Best Pract Res Clin Obstet Gynaecol


  8 in total

Review 1.  Hysterectomy, endometrial destruction, and levonorgestrel releasing intrauterine system (Mirena) for heavy menstrual bleeding: systematic review and meta-analysis of data from individual patients.

Authors:  L J Middleton; R Champaneria; J P Daniels; S Bhattacharya; K G Cooper; N H Hilken; P O'Donovan; M Gannon; R Gray; K S Khan; J Abbott; J Barrington; S Bhattacharya; M Y Bongers; J-L Brun; R Busfield; M Sowter; T J Clark; J Cooper; K G Cooper; S L Corson; K Dickersin; N Dwyer; M Gannon; J Hawe; R Hurskainen; W R Meyer; H O'Connor; S Pinion; A M Sambrook; W H Tam; I A A van Zon-Rabelink; E Zupi
Journal:  BMJ       Date:  2010-08-16

2.  The regulation of vascular endothelial growth factor by hypoxia and prostaglandin F₂α during human endometrial repair.

Authors:  Jacqueline A Maybin; Nikhil Hirani; Pamela Brown; Henry N Jabbour; Hilary O D Critchley
Journal:  J Clin Endocrinol Metab       Date:  2011-06-15       Impact factor: 5.958

Review 3.  Second generation endometrial ablation techniques for heavy menstrual bleeding: network meta-analysis.

Authors:  J P Daniels; L J Middleton; R Champaneria; K S Khan; K Cooper; B W J Mol; S Bhattacharya
Journal:  BMJ       Date:  2012-04-23

Review 4.  Endocrine check-up in adolescents and indications for referral: A guide for health care providers.

Authors:  Vincenzo De Sanctis; Ashraf T Soliman; Bernadette Fiscina; Heba Elsedfy; Rania Elalaily; Mohamed Yassin; Nicos Skordis; Salvatore Di Maio; Giorgio Piacentini; Mohamed El Kholy
Journal:  Indian J Endocrinol Metab       Date:  2014-11

5.  Ormeloxifene - Looking beyond contraception.

Authors:  Tapasi Pati; Kabita Chanania; Satyabhama Marandi; Jagadish Hansa
Journal:  J Midlife Health       Date:  2017 Jan-Mar

6.  The COVID-19 pandemic and the menstrual cycle: research gaps and opportunities.

Authors:  Gemma C Sharp; Abigail Fraser; Gemma Sawyer; Gabriella Kountourides; Kayleigh E Easey; Gemma Ford; Zuzanna Olszewska; Laura D Howe; Deborah A Lawlor; Alexandra Alvergne; Jacqueline A Maybin
Journal:  Int J Epidemiol       Date:  2022-06-13       Impact factor: 9.685

7.  LNG-IUS vs. medical treatments for women with heavy menstrual bleeding: A systematic review and meta-analysis.

Authors:  Sijing Chen; Jianhong Liu; Shiyi Peng; Ying Zheng
Journal:  Front Med (Lausanne)       Date:  2022-08-25

8.  The delivery of heavy menstrual bleeding services in England and Wales after publication of national guidelines: a survey of hospitals.

Authors:  Suzanne M Cox; David Cromwell; Tahir Mahmood; Allan Templeton; Benedetta La Corte; Jan van der Meulen
Journal:  BMC Health Serv Res       Date:  2013-11-25       Impact factor: 2.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.